Table 1.
Baseline characteristics of the 276 patients with locoregionally-advanced nasopharyngeal cancer in each treatment arm
| Variable | TPF + CCRT (n = 138) |
PF + CCRT (n = 138) |
P-Value* |
|---|---|---|---|
| Sex | .894 | ||
| Male | 99 (71.7) | 98 (71.0) | |
| Female | 39 (28.3) | 40 (29.0) | |
| Age, years | |||
| Median | 48 | 50 | |
| Range | 18–68 | 25–69 | |
| Karnofsky performance score | .626 | ||
| 100–90 | 130 (94.2) | 128 (92.6) | |
| 80–70 | 8 (5.8) | 10 (7.4) | |
| T category | .544 | ||
| T 1–2 | 25 (18.1) | 29 (21) | |
| T 3–4 | 113 (81.9) | 109 (79) | |
| N category | .801 | ||
| N 0–1 | 48 (34.8) | 50 (36.2) | |
| N 2–3 | 90 (65.2) | 88 (63.8) | |
| Stage | .312 | ||
| III | 86 (62.3) | 94 (68.1) | |
| IVA-B | 52 (37.7) | 44 (31.9) |
Values are shown as n (%) unless indicated otherwise.
*
Calculated using the χ2 test.